RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 112 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $460,000 | -32.1% | 221,308 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $677,000 | +26.5% | 221,308 | +2.3% | 0.00% | 0.0% |
| Q3 2015 | $535,000 | -37.4% | 216,390 | -18.7% | 0.00% | 0.0% |
| Q2 2015 | $854,000 | +36.4% | 266,009 | +51.8% | 0.00% | 0.0% |
| Q1 2015 | $626,000 | +28.3% | 175,200 | -18.9% | 0.00% | 0.0% |
| Q4 2014 | $488,000 | +46.1% | 215,934 | +25.5% | 0.00% | 0.0% |
| Q3 2014 | $334,000 | -24.8% | 172,034 | +26.1% | 0.00% | 0.0% |
| Q2 2014 | $444,000 | -30.4% | 136,434 | -31.0% | 0.00% | 0.0% |
| Q1 2014 | $638,000 | -10.0% | 197,691 | -14.5% | 0.00% | 0.0% |
| Q4 2013 | $709,000 | +34.3% | 231,300 | +56.6% | 0.00% | 0.0% |
| Q3 2013 | $528,000 | +143.3% | 147,727 | +126.5% | 0.00% | – |
| Q2 2013 | $217,000 | – | 65,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |